1-3 of 3
John E Coligan, PhD
Close
Sort by
Journal Articles

Harnessing Negative B Cell Selection to Overcome Drug-Resistance in Acute Lymphoblastic Leukemia

Zhengshan Chen, MD PhD, Seyedmehdi Shojaee, PhD, Huimin Geng, PhD, Jae-Woong Lee, PhD, Maike Buchner, PhD, Lars Klemm, Clifford A. Lowell, MD PhD, Elisabeth Paietta, PhD, Cheryl L. Willman, MD, William L. Carroll, MD, Ari Melnick, MD, Jae U. Jung, PhD, Hassan Jumaa, PhD, John E. Coligan, PhD, Silvia Bolland, PhD, Tak W. Mak, OC, PhD DSc, FRSC, FRS, Markus Muschen, MDPhD
Journal: Blood
Blood (2014) 124 (21): 792.
https://doi.org/10.1182/blood.V124.21.792.792
Published: 2014
Journal Articles

Inhibitory Receptors and Phosphatases Enable Oncogenic Tyrosine Kinase Signaling In B Cell Lineage Leukemia

Zhengshan Chen, MD, PhD, Seyedmehdi Shojaee, PhD, Huimin Geng, PhD, Jaewoong Lee, PhD, Maike Buchner, PhD, Lars Klemm, Clifford A. Lowell, MD, PhD, Elisabeth Paietta, PhD, Cheryl L. Willman, MD, William L. Carroll, MD, Ari M. Melnick, MD, Jae U. Jung, PhD, Hassan Jumaa, PhD, John E. Coligan, PhD, Silvia Bolland, PhD, Tak W. Mak, Markus Muschen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 229.
https://doi.org/10.1182/blood.V122.21.229.229
Published: 2013
Journal Articles

ITIM-Containing Inhibitory Receptors Are Required to Balance Oncogenic Signaling Strength in Ph + ALL

Zhengshan Chen, MD, PhD, Huimin Geng, PhD, Maike Buchner, PhD, Lars Klemm, MSc, Kaveh Hemati, BS, Seyedmehdi Shojaee, M.Sc., Mak W Tak, PhD, John E Coligan, PhD, William L. Carroll, MD, Cheryl L Willman, MD, Markus Muschen, MD
Journal: Blood
Blood (2012) 120 (21): 291.
https://doi.org/10.1182/blood.V120.21.291.291
Published: 2012